Nexalin Technology, Inc. ((Nasdaq: NXL) (“Nexalin” or the “Company”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the closing of its ...
Biopharmaceutical drug delivery company Halozyme Therapeutics (NASDAQ:HALO) reported revenue ahead of Wall Street’s ...
Matthew Ball, CEO of research house Epyllion, is known for his in-depth studies of the metaverse and the games industry.
Nexalin Technology, Inc. ( (Nasdaq: NXL) ("Nexalin" or the "Company"), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS) of the brain ...
Stellantis plans to launch a new lineup of what it's calling "muscle trucks" for its Ram brand despite elevated U.S. gas ...
Companies that control the underlying manufacturing capability to deliver new display technologies at scale tend to set the direction of the industry for the decade that follows ...
U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation ...
As part of plans for "strengthening Xbox’s console business," its new CSO Matthew Ball aims to elevate Microsoft's social ...
Anthropic's AI prayed without instruction in 90% of sessions and was trained to stop. Now the Vatican, the courts, and 500 ...
Key Points Interested in Intel Corporation? Here are five stocks we like better. Surging trading volume confirms that major ...
The Near-Infrared Spectrograph (NIRSpec) was able to detect chemical signatures. A visualization (not an actual image) of the NIRSpec velocity and distribution data is shown in the inset for oxygen ...
Despite its drivers failing to start three of the eight races, McLaren is still close behind Ferrari in the fight for second ...